Department of Diagnostic and Interventional Oncological Imaging, Institut Bergonié, Regional Comprehensive Cancer of Nouvelle-Aquitaine, 229, cours de l'Argonne, F-33076, Bordeaux cedex, France.
Univ Bordeaux, Imotion EA 7435, F-33000, Bordeaux, France.
Eur Radiol. 2021 Nov;31(11):8302-8314. doi: 10.1007/s00330-021-07998-4. Epub 2021 May 5.
Radiofrequency ablation (RFA) of lung metastases of colorectal origin can improve patient survival and quality of life. Our aim was to identify pre- and per-RFA features predicting local control of lung metastases following RFA.
This case-control single-center retrospective study included 119 lung metastases treated with RFA in 48 patients (median age: 60 years). Clinical, technical, and radiological data before and on early CT scan (at 48 h) were retrieved. After CT scan preprocessing, 64 radiomics features were extracted from pre-RFA and early control CT scans. Log-rank tests were used to detect categorical variables correlating with post-RFA local tumor progression-free survival (LTPFS). Radiomics prognostic scores (RPS) were developed on reproducible radiomics features using Monte-Carlo cross-validated LASSO Cox regressions.
Twenty-six of 119 (21.8%) nodules demonstrated local progression (median delay: 11.2 months). In univariate analysis, four non-radiomics variables correlated with post-RFA-LTPFS: nodule size (> 15 mm, p < 0.001), chosen electrode (with difference between covered array and nodule diameter < 20 mm or non-expandable electrode, p = 0.03), per-RFA intra-alveolar hemorrhage (IAH, p = 0.002), and nodule location into the ablation zone (not seen or in contact with borders, p = 0.005). The highest prognostic performance was reached with the multivariate model including a RPS built on 4 radiomics features from pre-RFA and early revaluation CT scans (cross-validated concordance index= 0.74) in which this RPS remained an independent predictor (cross-validated HR = 3.49, 95% confidence interval = [1.76 - 6.96]).
Technical, radiological, and radiomics features of the lung metastases before RFA and of the ablation zone at 48 h can help discriminate nodules at risk of local progression that could benefit from complementary local procedure.
• The highest prognostic performance to predict post-RFA LTPFS was reached with a parsimonious model including a radiomics score built with 4 radiomics features. • Nodule size, difference between electrode diameter, use of non-expandable electrode, per-RFA hemorrhage, and a tumor not seen or in contact with the ablation zone borders at 48-h CT were correlated with post-RFA LTPFS.
射频消融(RFA)治疗结直肠来源的肺转移瘤可改善患者的生存和生活质量。我们的目的是确定 RFA 前和 RFA 期间的特征,以预测 RFA 后肺转移瘤的局部控制情况。
本病例对照单中心回顾性研究纳入了 48 例患者的 119 个肺转移灶(中位年龄:60 岁),接受 RFA 治疗。我们回顾了 RFA 前和早期 CT 扫描(48 小时)时的临床、技术和影像学数据。在 CT 扫描预处理后,从 RFA 前和早期对照 CT 扫描中提取了 64 个放射组学特征。采用对数秩检验检测与 RFA 后局部肿瘤无进展生存期(LTPFS)相关的分类变量。使用蒙特卡罗交叉验证 LASSO Cox 回归,在可重复的放射组学特征上开发放射组学预后评分(RPS)。
119 个结节中有 26 个(21.8%)出现局部进展(中位延迟时间:11.2 个月)。单因素分析显示,4 个非放射组学变量与 RFA 后-LTPFS 相关:结节大小(>15mm,p<0.001)、选择的电极(覆盖阵列与结节直径之差<20mm 或不可扩展电极,p=0.03)、RFA 后肺泡内出血(IAH,p=0.002)和结节在消融区域内的位置(未被看见或与边界接触,p=0.005)。在包括 4 个 RFA 前和早期再评估 CT 扫描的放射组学特征的多变量模型中,达到了最高的预后性能(交叉验证一致性指数=0.74),其中该 RPS 仍然是一个独立的预测因素(交叉验证 HR=3.49,95%置信区间[1.76-6.96])。
RFA 前的肺转移瘤的技术、放射学和放射组学特征以及 48 小时时的消融区域特征可帮助区分有局部进展风险的结节,这些结节可能受益于补充性局部治疗。
• 预测 RFA 后 LTPFS 的最高预后性能是通过一个包含 4 个放射组学特征的放射组学评分模型实现的。• 结节大小、电极直径差异、使用不可扩展电极、RFA 后出血以及 48 小时 CT 上未见到或与消融区边界接触的肿瘤与 RFA 后 LTPFS 相关。